Mishkin GE - Search Results

1

Meeting the Challenge: The National Cancer Institute's Central Institutional Review Board for Multi-Site Research.

Massett HA, Hampp SL, Goldberg JL, Mooney M, Parreco LK, Minasian L, Montello M, Mishkin GE, Davis C, Abrams JS. Massett HA, et al. Among authors: mishkin ge. J Clin Oncol. 2018 Mar 10;36(8):819-824. doi: 10.1200/JCO.2017.76.9836. Epub 2018 Jan 31. J Clin Oncol. 2018. PMID: 29384720 Free PMC article. Review.

2

Challenges Facing Early Phase Trials Sponsored by the National Cancer Institute: An Analysis of Corrective Action Plans to Improve Accrual.

Massett HA, Mishkin G, Rubinstein L, Ivy SP, Denicoff A, Godwin E, DiPiazza K, Bolognese J, Zwiebel JA, Abrams JS. Massett HA, et al. Clin Cancer Res. 2016 Nov 15;22(22):5408-5416. doi: 10.1158/1078-0432.CCR-16-0338. Epub 2016 Jul 11. Clin Cancer Res. 2016. PMID: 27401246 Free PMC article. Review.

3

The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies.

Mishkin G, Minasian LM, Kohn EC, Noone AM, Temkin SM. Mishkin G, et al. Gynecol Oncol. 2016 Dec;143(3):611-616. doi: 10.1016/j.ygyno.2016.09.026. Epub 2016 Sep 30. Gynecol Oncol. 2016. PMID: 27697287

4

Raising Public Awareness of Clinical Trials: Development of Messages for a National Health Communication Campaign.

Massett HA, Dilts DM, Bailey R, Berktold J, Ledsky R, Atkinson NL, Mishkin G, Denicoff A, Padberg RM, Allen MP, Silver K, Carrington K, Johnson LE. Massett HA, et al. J Health Commun. 2017 May;22(5):373-385. doi: 10.1080/10810730.2017.1290715. Epub 2017 Mar 24. J Health Commun. 2017. PMID: 28339327

5

A Randomized Controlled Study Comparing the National Cancer Institute's Original and Revised Consent Form Templates.

Masset HA, Hiser M, Atkinson NL, Brittle C, Bailey R, Adler J, Mishkin GE, Denicoff AM, Roach N, Good M, Burgess D, Patrick L, Mooney M, Abrams JS. Masset HA, et al. Among authors: mishkin ge. IRB. 2017 Sep-Oct;39(5):1-7. IRB. 2017. PMID: 30703315 Clinical Trial.

6

Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN).

Massett HA, Mishkin G, Moscow JA, Gravell A, Steketee M, Kruhm M, Han SH, Barry B, Montello M, Zwiebel J, Abrams JS, Doroshow JH, Ivy SP. Massett HA, et al. Clin Cancer Res. 2019 Dec 1;25(23):6925-6931. doi: 10.1158/1078-0432.CCR-19-1754. Epub 2019 Aug 22. Clin Cancer Res. 2019. PMID: 31439585 Free PMC article.

7

Reporting of health-related quality of life endpoints in National Cancer Institute-supported cancer treatment trials.

St Germain D, Denicoff A, Torres A, Kelaghan J, McCaskill-Stevens W, Mishkin G, O'Mara A, Minasian LM. St Germain D, et al. Cancer. 2020 Jun 1;126(11):2687-2693. doi: 10.1002/cncr.32765. Epub 2020 Apr 1. Cancer. 2020. PMID: 32237256 Free article.

8

Update on Enrollment of Older Adults Onto National Cancer Institute National Clinical Trials Network Trials.

Mishkin GE, Denicoff AM, Best AF, Little RF. Mishkin GE, et al. J Natl Cancer Inst Monogr. 2022 Dec 15;2022(60):111-116. doi: 10.1093/jncimonographs/lgac017. J Natl Cancer Inst Monogr. 2022. PMID: 36519819 Free PMC article.

9

Drivers of Clinical Trial Participation-Demographics, Disparities, and Eligibility Criteria.

Mishkin G, Arnaldez F, Ivy SP. Mishkin G, et al. JAMA Oncol. 2019 Mar 1;5(3):305-306. doi: 10.1001/jamaoncol.2018.5949. JAMA Oncol. 2019. PMID: 30629085 No abstract available.

10

Biomarker Development: Bedside to Bench.

Mishkin GE, Kohn EC. Mishkin GE, et al. Clin Cancer Res. 2022 Jul 1;28(13):2722-2724. doi: 10.1158/1078-0432.CCR-22-0750. Clin Cancer Res. 2022. PMID: 35481871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters